Polatuzumab Vedotin With R-CHP Shows Strong Activity in Older DLBCL Patients

(MedPage Today) — At the recent annual meeting of the American Society of Hematology (ASH), a multicenter retrospective analysis used real-world data to examine the use of polatuzumab vedotin (Polivy) with rituximab, cyclophosphamide, doxorubicin, prednisone…